Shares of Insmed Incorporated ( NASDAQ:INSM – Get Rating ) have been given a consensus recommendation of 'Moderate Buy' by the thirteen ratings firms that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation and eleven have given a buy recommendation to the company. The average 1-year price objective among brokers that have covered the stock in the last year is $43.33. A number of equities analysts have commented on the stock.

https://www.dailypolitical.com/2023/04/30/insmed-incorporated-nasdaqinsm-given-consensus-recommendation-of-moderate-buy-by-analysts.html

#dailypolitical